Sleep deprivation is associated with risk of atherosclerosis in adults: JAHA

Published Date: 17 Feb 2023

United States: Infrequent sleep, particularly chronic sleep, in adults aged 45 and older is associated with numerous measures of...

Read Full News

Latest News

Skin of Color Savvy: A New Podcast Episode Following SOCS Media Day

Skin of Color Savvy: A New Podcast Episode Following SOCS Media Day

The HCPFive: Top News for Healthcare Providers from the Week of 11/16

The HCPFive: Top News for Healthcare Providers from the Week of 11/16

Durability of Biologics for Psoriasis Compared, Adjusted for Drug Switching Over Time

Durability of Biologics for Psoriasis Compared, Adjusted for Drug Switching Over Time

Rezpegaldesleukin Shows Strong Phase 2b Results for Atopic Dermatitis, Asthma

Rezpegaldesleukin Shows Strong Phase 2b Results for Atopic Dermatitis, Asthma

Mid Trial Update Released on Baricitinib for Frontal Fibrosing Alopecia

Mid Trial Update Released on Baricitinib for Frontal Fibrosing Alopecia

New 'heart percentile' calculator helps young adults grasp their long-term risk

A new Northwestern Medicine study introduces a first-of-its-kind online calculator that uses percentiles to help younger adults forecast and understand their risk of a heart event over the next 30 years. With rates of obesity, ...

Todays Updates

What’s Next for Dapirolizumab Pegol Following Lupus Phase 3 Trial, With Ed Vital, MD Ed Vital, MD

Phase 3 data show dapirolizumab pegol improved remission and disease stability in lupus; a second trial and patient-reported outcomes are now underway.

First Patient Dosed in Phase 2 Extension Study of Sabirnetug in Early Alzheimer Disease Louie Pasculli

Acumen Pharmaceuticals initiates a phase 2 trial extension for sabirnetug, targeting early Alzheimer disease and aiming for long-term safety insights.

NeurologyLive® Friday 5 — November 21, 2025 Isabella Ciccone, MPH

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending November 21, 2025.

Case Report Suggests Progressive Brain Atrophy May Occur in NMOSD Without Relapse Marco Meglio

A case report reveals cognitive decline and brain atrophy in a patient with NMOSD, highlighting potential subclinical neurodegeneration despite limited relapses.

Satralizumab Demonstrates Long-term Efficacy and Safety in Patients With NMOSD Louie Pasculli

A recent study confirms satralizumab's long-term safety and efficacy for treating neuromyelitis optica spectrum disorder, supporting its use as a maintenance therapy.

NeurologyLive® Brain Games: November 23, 2025 Marco Meglio, Louie Pasculli

Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is neural network plasticity after stroke!

Tapinarof Shows Early, Sustained Benefits in Pediatric Atopic Dermatitis, With Druhan Howell, MD Druhan Howell, MD

At ACAAI 2025, Howell discussed sub-analytical data showing early itch and skin improvements with tapinarof cream in children with AD aged 2–17 years.

Todays Updates

What’s Next for Dapirolizumab Pegol Following Lupus Phase 3 Trial, With Ed Vital, MD Ed Vital, MD

Phase 3 data show dapirolizumab pegol improved remission and disease stability in lupus; a second trial and patient-reported outcomes are now underway.

First Patient Dosed in Phase 2 Extension Study of Sabirnetug in Early Alzheimer Disease Louie Pasculli

Acumen Pharmaceuticals initiates a phase 2 trial extension for sabirnetug, targeting early Alzheimer disease and aiming for long-term safety insights.

NeurologyLive® Friday 5 — November 21, 2025 Isabella Ciccone, MPH

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending November 21, 2025.

Case Report Suggests Progressive Brain Atrophy May Occur in NMOSD Without Relapse Marco Meglio

A case report reveals cognitive decline and brain atrophy in a patient with NMOSD, highlighting potential subclinical neurodegeneration despite limited relapses.

Satralizumab Demonstrates Long-term Efficacy and Safety in Patients With NMOSD Louie Pasculli

A recent study confirms satralizumab's long-term safety and efficacy for treating neuromyelitis optica spectrum disorder, supporting its use as a maintenance therapy.

NeurologyLive® Brain Games: November 23, 2025 Marco Meglio, Louie Pasculli

Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is neural network plasticity after stroke!

Tapinarof Shows Early, Sustained Benefits in Pediatric Atopic Dermatitis, With Druhan Howell, MD Druhan Howell, MD

At ACAAI 2025, Howell discussed sub-analytical data showing early itch and skin improvements with tapinarof cream in children with AD aged 2–17 years.

Latest News

Skin of Color Savvy: A New Podcast Episode Following SOCS Media Day

The HCPFive: Top News for Healthcare Providers from the Week of 11/16

Durability of Biologics for Psoriasis Compared, Adjusted for Drug Switching Over Time

Rezpegaldesleukin Shows Strong Phase 2b Results for Atopic Dermatitis, Asthma

Mid Trial Update Released on Baricitinib for Frontal Fibrosing Alopecia

A new Northwestern Medicine study introduces a first-of-its-kind online calculator that uses percentiles to help younger adults forecast and understand their risk of a heart event over the next 30 years. With rates of obesity, ...

News All Time

Q&A: How to have a heart-healthy Thanksgiving

Thanksgiving is a time to gather with loved ones, give thanks, and savor the flavors of the season. But for anyone striving to eat heart-healthy, the holiday can present some challenges. With buttery sides, decadent desserts, ...

New pediatric basic life support guidelines seek to improve outcomes, optimize care, says co-author

While sudden cardiac arrest in a child or adolescent is rare—about 20,000 cases occur each year in the U.S.—the survival rate when it happens outside of a hospital is estimated to be under 20%. Significantly improving ...

Extending anti-clotting treatment linked to lower rates of new clots

Extending anti-clotting drugs beyond the initial treatment period of at least 90 days after a first blood clot is linked to lower rates of new clots developing compared with stopping treatment, finds a US study published ...

'Humanized' model developed to study heart valve stiffness

The first ever "humanized" model for aortic valve calcification paves the way for testing potential treatments.

Very low LDL-cholesterol correlates to fewer heart problems after stroke

Brigham and Women's Hospital's TIMI Study Group reports that in patients with prior ischemic stroke, very low achieved LDL-cholesterol correlated with fewer major adverse cardiovascular events and fewer recurrent strokes, ...

Protein found to be key in blood vessel healing after surgical injury

Surgeons in the United States perform nearly 600,000 coronary artery stent procedures and bypass surgeries every year.

Plant-based diet can prevent, reverse form of heart disease in animals with hypertension

Eating a plant-based diet consisting of fruits, vegetables, nuts and legumes can help prevent and reverse heart disease in rats that have high blood pressure, according to a study published by researchers in the Institute ...

High blood pressure in children nearly doubled from 2000–2020, global study finds

The rate of children and adolescents experiencing high blood pressure worldwide nearly doubled between 2000 and 2020, according to a new meta-analysis published in The Lancet Child & Adolescent Health journal.

Should you worry about melatonin and heart failure? The evidence isn't clear

A study presented at the American Heart Association's scientific meetings has raised concerns about melatonin, one of Britain's most commonly prescribed sleep aids. The findings suggest that long-term users face a higher ...

Effectiveness of anti-clotting meds after stent placement varied in people with diabetes

One year of dual antiplatelet therapy with one of two potent P2Y12 inhibitors—ticagrelor or prasugrel—in people with Type 1 or Type 2 diabetes who had received a drug-eluting stent did not offer the same level of benefit ...

LDL cholesterol improved among veterans in program with health coaches, other resources

A quality improvement program helped reduce "bad cholesterol" (LDL or low-density lipoprotein) levels among military veterans who have heart and blood vessel disease, according to a preliminary late-breaking science presentation ...

Researchers use AI and genetics to identify early signs of a rare, life-threatening heart condition

At Mayo Clinic, cardiologists Peter Noseworthy, M.D., and John Giudicessi, M.D., Ph.D., are uncovering the earliest signs of a genetic heart condition that often strikes without warning. Their work shows that early detection, ...

Many people miss out on the benefits of cardiac rehab. Here's why you shouldn't

To understand the benefits of cardiac rehabilitation, you can trust decades of research—or listen to Taelur Littlejohn's story.

Genetic testing trifecta predicts risk of sudden cardiac death and arrhythmia

In a new Northwestern Medicine study, scientists have developed a more precise genetic risk score to determine whether a person is likely to develop arrhythmia, an irregular heartbeat that can lead to serious conditions such ...

Sons of mothers with type 1 diabetes show early signs of vascular dysfunction

A new study from Karolinska Institutet and Stockholm University reveals that sons born to mothers with type 1 diabetes may develop early vascular dysfunction—independently of metabolic health. The finding may help shape ...

High blood pressure in your 30s tied to heart attack risk

People in their 30s may risk a heart attack or stroke in later life even when they have "normal" blood pressure, if it's too high or steeply rising, according to a new study led by UCL researchers.

Recommended News For You

Experts say oncology, primary care coordination necessary for best cancer patient outcomes

GLP-1 receptor agonists, cancer risk and questionable significance

Study finds 1 in 12 patients labeled as having 'benign' results actually had high-risk prostate cancer

Telemedicine services linked to reducing excess mortality

investigating radiation oncology applications of artificial general intelligence.

New BCMA-Directed Therapies Show Promise in Multiple Myeloma

Promising OS at 5 Years With Chemo-Free Combo in Urothelial Cancer

Recommended Articles For You

Breaking Down Leukocytoclastic Vasculitis: Causes, Symptoms and Treatment 

The Statistical Frontier of Hematology Oncology: Diagnostics, Therapies, and Future Horizons in Hematology Oncology 2025 

A Mural of Thrombus: Unlocking the Power of Art to Combat Cardiovascular Disease 

Revolutionizing Thyroid Cancer: Advances in Molecular Genetics and Personalized Treatment Approaches 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Elder Abuse: Red Flags to Look Out For While Receiving Care.

2.

Many Americans unaware of links between HPV and cancers, poll reveals

3.

For cancer patients who are not responding to chemotherapy, new genes and natural toxins offer hope.

4.

After cancer: Study explores caring-healing modalities for survivors

5.

Researchers investigate risk of developing multiple primary cancers after surviving bowel cancer

1.

Mechanistic Insights into Abraxane, Verzenio, and the Management of Chemotherapy-Induced Tachycardia

2.

Survival Rate Dynamics in Hematologic and Solid Malignancies

3.

Unlocking the Potential of Plinabulin: A New Frontier in Cancer Treatment

4.

Targeting BRAF V600E in mCRC: FOLFOX, Cetuximab & Encorafenib Strategies

5.

Transplant Oncology and Anti-Cancer Immunosuppressants: The Evolution of a Paradigm in Cancer Care

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Navigating the Complexities of Ph Negative ALL - Part XII

2.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part V

3.

Navigating the Complexities of Ph Negative ALL - Part XI

4.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion

5.

Navigating the Complexities of Ph Negative ALL - Part X

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot